On the contrary, a very recent study demonstrated that the anti-tumor activity of anti-PD-L1 mAbs in MC38 and CT26 syngeneic colon adenocarcinoma models was independent of FcγR engagement. This evidence concerns the gene FCGR2A and neoplasm.